Depakote ER: 500 mg PO qDay for 7 days; based on patient response, may increase and adjust dose to 500-1000 mg/day
Children taking valproic acid (Depakote®)— At first, 0
The starting dose of Depakote tablets for preventing migraine episodes is 250 mg twice daily
Starting dosage for acute manic bipolar disorder: 500–750 mg per day (or 25 mg/kg daily) and increase the dose by 30% to 50% every three days as tolerated
Your doctor may increase your dose as needed
How should I take Depakote? Take Depakote exactly as prescribed by your doctor
Depakote should be swallowed whole and should not be crushed or chewed (2
However, Depakote sprinkle capsules are not approved for this purpose
Depakote is indicated for prophylaxis of migraine headaches in adults
This medicine is sometimes used together with other seizure medications
The recommended starting dose of Depakote for the prevention of migraine is 250 mg twice daily
start dose and titrate slowly in elderly pts; adjust dose based on tx response and serum levels Serious side effects of Depakote that have been reported include: low platelet count (a type of blood cell involved in blood clotting) hypothermia (low body temperature) high level of ammonia in Initial dose: 0
This medicine is an anticonvulsant that works in the brain tissue to stop seizures
Although doses other than 1,000 mg once daily of Depakote ER have not been evaluated in patients with migraine, the effective dose range of Depakote (divalproex sodium delayed-release tablets) in these patients is 500-1,000
5
DEPAKOTE ® (divalproex sodium) delayed-release tablets, DEPAKOTE® ER (divalproex sodium) extended-release tablets, and DEPAKOTE ® Sprinkle Capsules (divalproex sodium delayed All women of childbearing age (including girls from the start of puberty) should talk to their healthcare DEPAKOTE prescription and dosage sizes information for physicians and healthcare professionals
2)
Children usually start with a dose of 5 to 10 milligrams (mg) for each kilogram (kg, about 2
All 13 patients received at least 5 full days of valproate maintained at or above 20 mg/kg/day, and valproate serum concentrations were 50 micrograms/ml (mean +/- SD = 88 + 25) by the second or third day of treatment
In addition, in clinical trials a starting dose of 20 mg valproate/kg body weight has also shown an acceptable safety profile
The dosage of Depakote depends on several patient factors including age, the medical condition for which Depakote is prescribed, sensitivity to side effects, the presence of dehydration, and nutritional status
Depakote typically comes in 250mg and 500mg capsules, and the recommended dose for anxiety is primarily based on body weight and age